Anti-Human CD279 (PD-1) (Nivolumab) - 50 mg LT1200-50 mg from Leinco Technologies, Inc.

Product Specs
ItemAnti-Human CD279 (PD-1) (Nivolumab) - 50 mg
CompanyLeinco Technologies, Inc.
Price Pricing Info Supplier Page View Company Product Page
Catalog NumberLT1200-50 mg
ClonalityBiosimilar Recombinant Human Monoclonal Antibody
FormatThis biosimilar antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added. Due to inherent biochemical properties of antibodies, certain products may be prone to precipitation over time. Precipitation may be removed by aseptic centrifugation and/or filtration
ApplicationsB, FA, FC, IHC
Clone5C4.B8
IsotypeHuman IgG1κ
Research AreaCostimulatory Molecules, Immuno-Oncology, Immunology
TargetPD-1
Conjugate/TagUnconjugated
Quantity50 mg
Concentration≥ 5.0 mg/ml
ReactivityHuman, Cynomolgus Monkey
NCBI Full Gene Nameprogrammed cell death 1
NCBI Gene AliasesCD279, PD-1, PD1, SLEB2, hPD-1, hPD-l, hSLE1
Antibody TypeBiosimilar Recombinant Human Antibody
ImmunogenHuman PD-1
Purity≥95% monomer by analytical SEC